These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 16382373)

  • 1. Botulinum toxin treatment for oropharyngeal dysphagia due to tetanus.
    Restivo DA; Marchese-Ragona R
    J Neurol; 2006 Mar; 253(3):388-9. PubMed ID: 16382373
    [No Abstract]   [Full Text] [Related]  

  • 2. Botulinum toxin and rehabilitation treatment in inclusion body myositis for severe oropharyngeal dysphagia.
    Di Pede C; Masiero S; Bonsangue V; Ragona RM; Del Felice A
    Neurol Sci; 2016 Oct; 37(10):1743-5. PubMed ID: 27098244
    [No Abstract]   [Full Text] [Related]  

  • 3. Solving dysphagia due to cricopharyngeal muscle dysfunction with botulinum toxin.
    Marchese-Ragona R; Marioni G; Restivo DA; Staffieri A
    Eur Arch Otorhinolaryngol; 2005 Mar; 262(3):250-1; author reply 252-3. PubMed ID: 15678333
    [No Abstract]   [Full Text] [Related]  

  • 4. Successful botulinum toxin treatment of dysphagia in a young child with nemaline myopathy.
    Restivo DA; Giuffrida S; Marchese Ragona R; Falsaperla R
    Dysphagia; 2001; 16(3):228-9. PubMed ID: 11453573
    [No Abstract]   [Full Text] [Related]  

  • 5. Botulinum toxin improves dysphagia associated with multiple sclerosis.
    Restivo DA; Marchese-Ragona R; Patti F; Solaro C; Maimone D; Zappalá G; Pavone A
    Eur J Neurol; 2011 Mar; 18(3):486-90. PubMed ID: 20731706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum toxin for dysphagia due to cricopharyngeal dysfunction.
    Moerman M; Callier Y; Dick C; Vermeersch H
    Eur Arch Otorhinolaryngol; 2002 Jan; 259(1):1-3. PubMed ID: 11954918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ALS dysphagia pathophysiology: differential botulinum toxin response.
    Restivo DA; Casabona A; Nicotra A; Zappia M; Elia M; Romano MC; Alfonsi E; Marchese-Ragona R
    Neurology; 2013 Feb; 80(7):616-20. PubMed ID: 23345638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum toxin alleviates dysphagia of patients with inclusion body myositis.
    Schrey A; Airas L; Jokela M; Pulkkinen J
    J Neurol Sci; 2017 Sep; 380():142-147. PubMed ID: 28870555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term botulinum toxin treatment for dysphagia due to large epiphrenic diverticulum in elderly patients: a report of two cases.
    Katsinelos P; Chatzimavroudis G; Zavos C; Pilpilidis I; Paroutoglou G; Kountouras J
    Dysphagia; 2009 Mar; 24(1):109-13. PubMed ID: 18633569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Injection of botulinum toxin A to the upper esophageal sphincter for oropharyngeal dysphagia in two patients with inclusion body myositis.
    Liu LW; Tarnopolsky M; Armstrong D
    Can J Gastroenterol; 2004 Jun; 18(6):397-9. PubMed ID: 15190396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum toxin in the treatment of cricopharyngeal dysphagia.
    Haapaniemi JJ; Laurikainen EA; Pulkkinen J; Marttila RJ
    Dysphagia; 2001; 16(3):171-5. PubMed ID: 11453562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endoscopic-guided injection of botulinum toxin into the cricopharyngeus muscle: our experience.
    Sharma SD; Kumar G; Eweiss A; Chatrath P; Kaddour H
    J Laryngol Otol; 2015 Oct; 129(10):990-5. PubMed ID: 26446761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum toxin treatment for cricopharyngeal dysfunction.
    Shaw GY; Searl JP
    Dysphagia; 2001; 16(3):161-7. PubMed ID: 11453560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin for muscle spasm after tetanus.
    Gaber TA; Mannemela S
    J R Soc Med; 2005 Feb; 98(2):63. PubMed ID: 15684359
    [No Abstract]   [Full Text] [Related]  

  • 15. Improvement of masseter spasticity by botulinum toxin facilitates PEG placement in amyotrophic lateral sclerosis.
    Restivo DA; Lanza S; Marchese-Ragona R; Palmeri A
    Gastroenterology; 2002 Nov; 123(5):1749-50. PubMed ID: 12404262
    [No Abstract]   [Full Text] [Related]  

  • 16. [Botulinium toxin in ENT].
    Klap P
    Ann Otolaryngol Chir Cervicofac; 2006 Dec; 123(6):306-11. PubMed ID: 17202988
    [No Abstract]   [Full Text] [Related]  

  • 17. Botulinum toxin for cricopharyngeal dysfunction in Parkinson's disease.
    Restivo DA; Palmeri A; Marchese-Ragona R
    N Engl J Med; 2002 Apr; 346(15):1174-5. PubMed ID: 11948283
    [No Abstract]   [Full Text] [Related]  

  • 18. Tetanus: pathophysiology, treatment, and the possibility of using botulinum toxin against tetanus-induced rigidity and spasms.
    Hassel B
    Toxins (Basel); 2013 Jan; 5(1):73-83. PubMed ID: 23299659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Botulinum toxin for neurogenic dysphagia after brainstem ischemia : Single injection as a treatment of an esophageal opening disorder].
    Schradt F; Stösser S; Hänle M; Kassubek J; Lindner-Pfleghar B; Neugebauer H
    Nervenarzt; 2019 Feb; 90(2):191-193. PubMed ID: 30171305
    [No Abstract]   [Full Text] [Related]  

  • 20. Botulinum toxin treatment improves dysphagia in patients with oculopharyngeal muscular dystrophy and sporadic inclusion body myositis.
    Witting N; Daugaard D; Prytz S; Biernat H; Diederichsen LP; Vissing J
    J Neurol; 2022 Aug; 269(8):4154-4160. PubMed ID: 35244767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.